The University of Southampton
University of Southampton Institutional Repository

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

Reitamo, Sakari, Rustin, Malcolm, Ruzicka, Thomas, Cambazard, Frédéric, Kalimo, Kirsti, Friedmann, Peter S., Schoepf, Erwin, Lahfa, Mourad, Diepgen, Thomas L., Judodihardjo, Harryono, Wollenberg, Andreas, Berth-Jones, John and Bieber, Thomas (2002) Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis Journal of Allergy and Clinical Immunology, 109, (3), pp. 547-555. (doi:10.1067/mai.2002.121832).

Record type: Article

Abstract

Background: Vehicle-controlled studies have demonstrated the efficacy and safety of tacrolimus ointment for patients with atopic dermatitis.
Objective: This study was undertaken to compare 0.03% and 0.1% tacrolimus ointment with 0.1% hydrocortisone-17-butyrate ointment, a midpotent to potent topical corticosteroid, in the treatment of adult patients with moderate-to-severe atopic dermatitis.
Methods: Patients applied ointment twice daily to all affected areas for 3 weeks in this multicenter, randomized, double-blind, parallel-group study. The primary endpoint was the modified eczema area and severity index (mEASI) mean area under the curve as a percentage of baseline.
Results: Five hundred seventy patients were randomized and received treatment. Discontinuations included 22 of 193 patients from the 0.03% tacrolimus group, 22 of 191 patients from the 0.1% tacrolimus group, and 17 of 186 patients from the hydrocortisone butyrate group. The median mEASI mean area under the curve as a percentage of baseline was 47.0%, 36.5%, and 36.1% for patients who received 0.03% tacrolimus, 0.1% tacrolimus, and 0.1% hydrocortisone butyrate, respectively. There was no statistically significant difference between 0.1% tacrolimus and 0.1% hydrocortisone butyrate; however, the lower improvement in mEASI for 0.03% tacrolimus was statistically significant when compared with 0.1% tacrolimus (P < .001) or hydrocortisone butyrate (P = .002). Skin burning and pruritus at the application site showed a higher incidence in the tacrolimus treatment groups than in the hydrocortisone butyrate group (P < .05). Laboratory parameters showed no treatment differences and no marked changes over time.
Conclusions: The efficacy of 0.1% tacrolimus ointment was similar to that of 0.1% hydrocortisone butyrate ointment and was lower for 0.03% tacrolimus ointment. No serious safety concerns were identified.

Full text not available from this repository.

More information

Published date: 2002

Identifiers

Local EPrints ID: 27351
URI: http://eprints.soton.ac.uk/id/eprint/27351
ISSN: 0091-6749
PURE UUID: 202685d6-c844-42a0-9b19-6a0676c4c8ab

Catalogue record

Date deposited: 28 Apr 2006
Last modified: 17 Jul 2017 16:04

Export record

Altmetrics

Contributors

Author: Sakari Reitamo
Author: Malcolm Rustin
Author: Thomas Ruzicka
Author: Frédéric Cambazard
Author: Kirsti Kalimo
Author: Peter S. Friedmann
Author: Erwin Schoepf
Author: Mourad Lahfa
Author: Thomas L. Diepgen
Author: Harryono Judodihardjo
Author: Andreas Wollenberg
Author: John Berth-Jones
Author: Thomas Bieber

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×